Concepedia

R.L. Kendall

RK

Statistics

Publications

6

Citations

1.9K

H-Index

6

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

R.L. Kendall is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, protein synthesis, and proteomics.

Top concepts

Publications per year

1991–2012

6

Publications

6

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

R.L. Kendall, Kenneth A. Thomas · Proceedings of the National Academy of Sciences · 1993 · 1.4K citations · Full text

, , +16

Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes.

Stuart M. Arfin, R.L. Kendall, Laurence S. Hall et al. · Proceedings of the National Academy of Sciences · 1995 · 256 citations · Full text

, , +16

Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins.

R.L. Kendall, Ralph Bradshaw · Journal of Biological Chemistry · 1992 · 99 citations · Full text

, , +21

Specificity of Vascular Endothelial Cell Growth Factor Receptor Ligand Binding Domains

R.L. Kendall, Gang Wang, Jerry DiSalvo et al. · Biochemical and Biophysical Research Communications · 1994 · 84 citations

, , +10

Anti-tumor activity of motesanib in a medullary thyroid cancer model.

Angela Coxon, James Bready, Stephen A. Kaufman et al. · PubMed · 2012 · 24 citations

1–5 of 6